LCA5L

gene
On this page

Also known as MGC33295

Summary

LCA5L (lebercilin LCA5 like, HGNC:1255) is a protein-coding gene on chromosome 21q22.2, encoding Lebercilin-like protein (O95447).

Predicted to be involved in intraciliary transport. Predicted to be active in axoneme.

Source: NCBI Gene 150082 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 4 total
  • MANE Select transcript: NM_152505

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:1255
Approved symbolLCA5L
Namelebercilin LCA5 like
Location21q22.2
Locus typegene with protein product
StatusApproved
AliasesMGC33295
Ensembl geneENSG00000157578
Ensembl biotypeprotein_coding
Entrez150082

Gene structure

Transcript identifiers

Ensembl transcripts: 23 — 15 protein_coding, 6 protein_coding_CDS_not_defined, 2 retained_intron

ENST00000288350, ENST00000358268, ENST00000380671, ENST00000411566, ENST00000415863, ENST00000418018, ENST00000426783, ENST00000434281, ENST00000438404, ENST00000448288, ENST00000451131, ENST00000456017, ENST00000459939, ENST00000466954, ENST00000468009, ENST00000480612, ENST00000484878, ENST00000485895, ENST00000490184, ENST00000491625, ENST00000495240, ENST00000855513, ENST00000951471

RefSeq mRNA: 22 — MANE Select: NM_152505 NM_001384285, NM_001384286, NM_001384287, NM_001384288, NM_001384289, NM_001384291, NM_001384292, NM_001384293, NM_001384294, NM_001384295, NM_001384296, NM_001384297, NM_001384298, NM_001384299, NM_001384300, NM_001384301, NM_001384302, NM_001384304, NM_001384308, NM_001384310, NM_001384313, NM_152505

CCDS: CCDS13665, CCDS93098

Canonical transcript exons

ENST00000288350 — 11 exons

ExonStartEnd
ENSE000010335933942297639423490
ENSE000013673193942913139429211
ENSE000013801423944413539444201
ENSE000013916883943542039435573
ENSE000016439403944572539445778
ENSE000034915743941171839411802
ENSE000035037893942070639420843
ENSE000036049593941026439410367
ENSE000036088803940997939410096
ENSE000037874813942817239428503
ENSE000039138183940572839406612

Expression profiles

Bgee: expression breadth ubiquitous, 175 present calls, max score 96.80.

FANTOM5 (CAGE): breadth broad, TPM avg 1.3821 / max 86.6083, expressed in 673 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1905021.3821673

Top tissues by expression

256 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left testisUBERON:000453396.80gold quality
right testisUBERON:000453496.30gold quality
spermCL:000001995.37gold quality
testisUBERON:000047394.36gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047391.21gold quality
buccal mucosa cellCL:000233690.53gold quality
bronchial epithelial cellCL:000232889.42gold quality
right uterine tubeUBERON:000130289.02gold quality
adult organismUBERON:000702388.10gold quality
bronchusUBERON:000218587.45gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099186.92gold quality
olfactory segment of nasal mucosaUBERON:000538683.71gold quality
mucosa of paranasal sinusUBERON:000503081.53gold quality
tibialis anteriorUBERON:000138576.33silver quality
gastrocnemiusUBERON:000138876.14gold quality
muscle of legUBERON:000138375.80gold quality
calcaneal tendonUBERON:000370175.57gold quality
adrenal tissueUBERON:001830374.68gold quality
fallopian tubeUBERON:000388974.56gold quality
islet of LangerhansUBERON:000000674.34gold quality
left adrenal glandUBERON:000123473.45gold quality
left adrenal gland cortexUBERON:003582573.25gold quality
epithelium of nasopharynxUBERON:000195173.13silver quality
nasopharynxUBERON:000172873.12silver quality
hindlimb stylopod muscleUBERON:000425272.89gold quality
right adrenal glandUBERON:000123372.85gold quality
right lobe of thyroid glandUBERON:000111972.80gold quality
skeletal muscle organUBERON:001489272.63gold quality
left lobe of thyroid glandUBERON:000112072.44gold quality
right adrenal gland cortexUBERON:003582772.43gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-GEOD-134144yes30.52
E-ANND-3yes6.16
E-GEOD-124858no113.91

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 1)

  • RNA-seq evidence of biallelic expression of LCA5L and 10 neighboring genes in at least one primary human tissue tested indicates that the expression of LCA5L is uncoupled from the control of the maternally inherited 5mCpG imprints at the WRB differentially methylated region (DMR) in disomic controls or trisomy (Down syndrome) individuals. (PMID:27100087)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
mus_musculusLca5lENSMUSG00000045275
rattus_norvegicusLca5lENSRNOG00000028248
drosophila_melanogasterCG6652FBGN0036687

Paralogs (1): LCA5 (ENSG00000135338)

Protein

Protein identifiers

Lebercilin-like proteinO95447 (reviewed: O95447)

Alternative names: Leber congenital amaurosis 5-like protein

All UniProt accessions (11): O95447, A0A1D5RMP5, C9J198, C9J293, C9J5D2, C9J9Z3, C9JFB6, C9JIJ8, C9JRD7, C9JYR0, U3KPS7

UniProt curated annotations — full annotation on UniProt →

Similarity. Belongs to the LCA5 family.

RefSeq proteins (21): NP_001371214, NP_001371215, NP_001371216, NP_001371217, NP_001371218, NP_001371220, NP_001371221, NP_001371222, NP_001371223, NP_001371224, NP_001371225, NP_001371226, NP_001371227, NP_001371228, NP_001371229, NP_001371230, NP_001371231, NP_001371233, NP_001371239, NP_001371242, NP_689718* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR026188Lebercilin-likeFamily
IPR028933Lebercilin_domDomain

Pfam: PF15619

UniProt features (15 total): region of interest 5, compositionally biased region 4, coiled-coil region 3, sequence variant 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-O95447-F162.760.26

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 49 (showing top): WANG_LMO4_TARGETS_DN, GOBP_CILIUM_ORGANIZATION, GOBP_CELL_PROJECTION_ORGANIZATION, chr21q22, BIDUS_METASTASIS_UP, GOCC_CYTOPLASMIC_REGION, GOCC_CILIUM, DODD_NASOPHARYNGEAL_CARCINOMA_DN, CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY, GOBP_INTRACILIARY_TRANSPORT, GOBP_INTRACELLULAR_TRANSPORT, YAP1_DN, GOBP_MICROTUBULE_BASED_TRANSPORT, GLI3_TARGET_GENES, ZFHX3_TARGET_GENES

GO Biological Process (1): intraciliary transport (GO:0042073)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (1): axoneme (GO:0005930)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cilium1
transport along microtubule1
cilium organization1
binding1
cytoskeleton1
microtubule1
ciliary plasm1
cellular anatomical structure1

Protein interactions and networks

STRING

835 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
LCA5LPSMG1O95456698
LCA5LSH3BGRP55822651
LCA5LKRTAP21-2Q3LI59585
LCA5LSH3BGRLO75368568
LCA5LMTMR9Q96QG7542
LCA5LXKR6Q5GH73539
LCA5LFAM178BQ8IXR5531
LCA5LB3GALT5Q9Y2C3529
LCA5LPFDN5Q99471497
LCA5LCCM2Q9BSQ5488
LCA5LLCA5Q86VQ0472
LCA5LBRWD1Q9NSI6464
LCA5LCCDC60Q8IWA6457
LCA5LSTON1Q9Y6Q2431
LCA5LRSPH1Q8WYR4402

IntAct

104 interactions, top by confidence:

ABTypeScore
TPM3LCA5Lpsi-mi:“MI:0915”(physical association)0.670
LCA5LTFIP11psi-mi:“MI:0915”(physical association)0.670
LCA5LTPM3psi-mi:“MI:0915”(physical association)0.670
TFIP11LCA5Lpsi-mi:“MI:0915”(physical association)0.670
LCA5LNMIpsi-mi:“MI:0915”(physical association)0.560
TPM3LCA5Lpsi-mi:“MI:0915”(physical association)0.560
NMILCA5Lpsi-mi:“MI:0915”(physical association)0.560
LCA5LTPM3psi-mi:“MI:0915”(physical association)0.560
LCA5Lpsi-mi:“MI:0915”(physical association)0.560
LCA5LPRPHpsi-mi:“MI:0915”(physical association)0.560
LCA5LEXOSC5psi-mi:“MI:0915”(physical association)0.560
LCA5LPBXIP1psi-mi:“MI:0915”(physical association)0.560
LCA5LKRT75psi-mi:“MI:0915”(physical association)0.560
LCA5LKRT76psi-mi:“MI:0915”(physical association)0.560
FCHSD2LCA5Lpsi-mi:“MI:0915”(physical association)0.560
LCA5LCCDC197psi-mi:“MI:0915”(physical association)0.560
LCA5LKRT80psi-mi:“MI:0915”(physical association)0.560
LCA5LTSGA10IPpsi-mi:“MI:0915”(physical association)0.560

BioGRID (37): LCA5L (Two-hybrid), LCA5L (Two-hybrid), LCA5L (Two-hybrid), LCA5L (Two-hybrid), LCA5L (Affinity Capture-MS), PCM1 (Affinity Capture-MS), LCA5L (Affinity Capture-MS), LCA5L (Two-hybrid), LCA5L (Two-hybrid), LCA5L (Two-hybrid), LCA5L (Two-hybrid), PBXIP1 (Two-hybrid), IKBIP (Two-hybrid), KRT80 (Two-hybrid), KRT75 (Two-hybrid)

ESM2 similar proteins: A0AUZ9, A0JMF7, A1L2Y1, A3KMW7, A8MT70, A8MW92, A9JRX0, B0CM36, B0S6S9, B7ZS37, D3Z987, F1QB81, O95447, P40649, Q0IHW6, Q0P5X5, Q14B48, Q15468, Q3U285, Q3V089, Q49A88, Q4R815, Q4V9H5, Q5CZC0, Q5DTI6, Q5REF4, Q5T1N1, Q5ZJK5, Q66H35, Q6NRH7, Q6NRK3, Q6ZRS4, Q6ZU52, Q80VP2, Q80WQ8, Q8BLG0, Q8CB14, Q8CCJ9, Q8IUR6, Q8IX21

Diamond homologs: A7E3D8, B0CM36, O95447, Q4R3Q7, Q5U2Y9, Q80ST9, Q86VQ0, Q8C0X0

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 27 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

GO biological processes:

GO termPartnersFoldFDR
intermediate filament organization548.1×2e-05

Disease & clinical

Clinical variants and AI predictions

ClinVar

4 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance2
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1015 predictions. Top by Δscore:

VariantEffectΔscore
21:39406611:ATC:Aacceptor_loss1.0000
21:39406612:TC:Tacceptor_loss1.0000
21:39406613:C:Aacceptor_loss1.0000
21:39406613:C:CCacceptor_gain1.0000
21:39409974:ATTAC:Adonor_loss1.0000
21:39409975:TTAC:Tdonor_loss1.0000
21:39409976:TACCT:Tdonor_loss1.0000
21:39409977:A:ACdonor_gain1.0000
21:39409978:C:CCdonor_gain1.0000
21:39409978:C:CGdonor_loss1.0000
21:39409978:CCTT:Cdonor_gain1.0000
21:39409995:AGAAT:Adonor_gain1.0000
21:39410094:ACCCT:Aacceptor_loss1.0000
21:39410097:C:CCacceptor_gain1.0000
21:39410099:G:GCacceptor_gain1.0000
21:39410104:T:Cacceptor_gain1.0000
21:39410104:T:TCacceptor_gain1.0000
21:39420734:T:TAdonor_gain1.0000
21:39420842:CT:Cacceptor_gain1.0000
21:39406608:TAAAT:Tacceptor_gain0.9900
21:39410092:TTACC:Tacceptor_gain0.9900
21:39410093:TACC:Tacceptor_gain0.9900
21:39410094:ACC:Aacceptor_gain0.9900
21:39410095:CC:Cacceptor_gain0.9900
21:39410095:CCC:Cacceptor_gain0.9900
21:39410096:CC:Cacceptor_gain0.9900
21:39410099:G:Cacceptor_gain0.9900
21:39410102:A:ACacceptor_gain0.9900
21:39410102:A:Cacceptor_gain0.9900
21:39410103:T:TCacceptor_gain0.9900

AlphaMissense

4455 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
21:39423034:A:GL260P0.987
21:39423172:A:GL214P0.986
21:39423260:C:GA185P0.986
21:39406317:G:CF526L0.985
21:39406317:G:TF526L0.985
21:39406319:A:GF526L0.985
21:39423130:A:GL228P0.985
21:39406086:A:CF603L0.984
21:39406086:A:TF603L0.984
21:39406088:A:GF603L0.984
21:39423280:A:GL178P0.984
21:39420722:A:GL320P0.983
21:39420710:A:GL324P0.981
21:39423079:A:GL245P0.981
21:39423164:A:GS217P0.981
21:39411792:C:GR329P0.980
21:39411786:A:GL331P0.978
21:39420827:A:GL285P0.978
21:39420765:C:GA306P0.977
21:39406297:A:GL533P0.976
21:39423175:A:GL213P0.975
21:39406090:A:GL602P0.974
21:39423205:T:GH203P0.974
21:39423352:A:GL154P0.971
21:39411759:C:GR340P0.970
21:39423052:A:GL254P0.968
21:39420794:A:GL296P0.963
21:39420800:C:GR294P0.963
21:39423042:C:AR257S0.962
21:39423042:C:GR257S0.962

dbSNP variants (sampled 300 via entrez): RS1000007702 (21:39431803 A>G), RS1000123303 (21:39431503 AAT>A), RS1000134360 (21:39445607 T>G), RS1000186755 (21:39406547 C>G,T), RS1000377015 (21:39409685 T>G), RS1000438592 (21:39418699 C>T), RS1000441317 (21:39439980 T>C), RS1000516915 (21:39416451 G>A), RS1000563144 (21:39408495 T>C), RS1000611342 (21:39421368 G>A,T), RS1000622679 (21:39421178 C>T), RS1000721147 (21:39414734 CTCTCTCTCTG>C), RS1000786001 (21:39413496 G>A), RS1000819447 (21:39427555 A>G), RS1000875928 (21:39434671 C>T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST004068_64Venous thromboembolism adjusted for sickle cell variant rs77121243-T9.000000e-06
GCST006629_25Pulse pressure1.000000e-09
GCST010204_176Low density lipoprotein cholesterol levels1.000000e-13

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0005763pulse pressure measurement
EFO:0004611low density lipoprotein cholesterol measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

12 total (human), top 12 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, increases expression3
Air Pollutantsincreases abundance, increases expression2
bisphenol Aincreases methylation, affects cotreatment1
1,6-hexamethylene diisocyanateincreases methylation1
sodium arseniteincreases expression1
bisphenol Sincreases methylation1
Fulvestrantaffects cotreatment, increases methylation1
Acetaminophenincreases expression1
Smokeincreases expression, increases abundance1
Tobacco Smoke Pollutiondecreases expression1
S-Nitrosoglutathionedecreases expression1
Particulate Matterincreases abundance, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): venous thromboembolism